- Home
- Publications
- Publication Search
- Publication Details
Title
Novel therapies for children with acute myeloid leukaemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume 27, Issue 7, Pages 1451-1460
Publisher
Springer Nature
Online
2013-04-08
DOI
10.1038/leu.2013.106
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How can attrition rates be reduced in cancer drug discovery?
- (2013) Lucas Moreno et al. Expert Opinion on Drug Discovery
- Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
- (2013) Gertjan J.L. Kaspers et al. JOURNAL OF CLINICAL ONCOLOGY
- Fractionated doses of gemtuzumab ozogamicin combined with 3 + 7 induction chemotherapy as salvage treatment for young patients with acute myeloid leukemia in first relapse
- (2012) J. V. Malfuson et al. ANNALS OF HEMATOLOGY
- Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
- (2012) U. Creutzig et al. BLOOD
- A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
- (2012) G. L. Uy et al. BLOOD
- Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
- (2012) H. Hasle et al. BLOOD
- Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation
- (2012) C. H. Man et al. BLOOD
- Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
- (2012) J. A. Pollard et al. BLOOD
- Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL
- (2012) Qiang Wen et al. CELL
- Efficacy of tosedostat, a novel, oral agent for elderly patients with relapsed or refractory acute myeloid leukemia: a review of the Phase II OPAL trial
- (2012) Michael S Mathisen et al. Future Oncology
- Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- (2012) Guillermo Garcia-Manero et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors
- (2012) A B Williams et al. LEUKEMIA
- Abrogation of MLL–AF10 and CALM–AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l
- (2012) L Chen et al. LEUKEMIA
- Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
- (2012) A S Moore et al. LEUKEMIA
- Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia
- (2012) R Swords et al. LEUKEMIA
- Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target
- (2012) S A Hartsink-Segers et al. LEUKEMIA
- Dasatinib inhibits proliferation and induces apoptosis in the KASUMI-1 cell line bearing the t(8;21)(q22;q22) and the N822K c-kit mutation
- (2012) Vassiliki E. Mpakou et al. LEUKEMIA RESEARCH
- Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
- (2012) Catherine C. Smith et al. NATURE
- Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells
- (2012) Chengzhi Xie et al. PEDIATRIC BLOOD & CANCER
- A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen
- (2011) Prakash Satwani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo
- (2011) T. Sato et al. BLOOD
- Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia
- (2011) B. Lowenberg et al. BLOOD
- Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007
- (2011) G. M. Dores et al. BLOOD
- Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
- (2011) M. Levis et al. BLOOD
- Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a Paediatric Oncology Group study
- (2011) Stanley Chaleff et al. BRITISH JOURNAL OF HAEMATOLOGY
- Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial
- (2011) Brenda E. S. Gibson et al. BRITISH JOURNAL OF HAEMATOLOGY
- AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia
- (2011) Todd M. Cooper et al. CANCER
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- The clinical development of FLT3 inhibitors in acute myeloid leukemia
- (2011) Steven Knapper EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia
- (2011) B. V. Balgobind et al. HAEMATOLOGICA
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia
- (2011) Hiroto Inaba et al. JOURNAL OF CLINICAL ONCOLOGY
- Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
- (2011) Ching-Hon Pui et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic Advances in Acute Myeloid Leukemia
- (2011) Alan Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
- (2011) D A Pollyea et al. LEUKEMIA
- Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML–BFM and DCOG study groups
- (2011) F Damm et al. LEUKEMIA
- Landscape of TET2 mutations in acute myeloid leukemia
- (2011) S Weissmann et al. LEUKEMIA
- DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia
- (2011) K H Metzeler et al. LEUKEMIA
- Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study
- (2011) Haifa K. Al-Ali et al. LEUKEMIA & LYMPHOMA
- Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia hasin vitrobut limited clinical activity
- (2011) Steven Lane et al. LEUKEMIA & LYMPHOMA
- Adaptation of the plasma inhibitory activity assay to detect Aurora, ABL and FLT3 kinase inhibition by AT9283 in pediatric leukemia
- (2011) Jennifer E. Podesta et al. LEUKEMIA RESEARCH
- Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C
- (2011) M.T. Corsetti et al. LEUKEMIA RESEARCH
- Comprehensive Predictive Biomarker Analysis for MEK Inhibitor GSK1120212
- (2011) J. Jing et al. MOLECULAR CANCER THERAPEUTICS
- Genetic and epigenetic similarities and differences between childhood and adult AML
- (2011) Caroline Juhl-Christensen et al. PEDIATRIC BLOOD & CANCER
- Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group
- (2011) Phoenix A. Ho et al. PEDIATRIC BLOOD & CANCER
- Targeted Drug Delivery by Gemtuzumab Ozogamicin: Mechanism-Based Mathematical Model for Treatment Strategy Improvement and Therapy Individualization
- (2011) Eva Jager et al. PLoS One
- C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice
- (2011) Y.-Y. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Epigenetic Programs in MLL-Rearranged Leukemias
- (2011) K. M. Bernt et al. Hematology-American Society of Hematology Education Program
- Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML
- (2010) J. A. Pollard et al. BLOOD
- Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program
- (2010) K Hübel et al. BONE MARROW TRANSPLANTATION
- Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation
- (2010) Hiroto Inaba et al. CANCER
- Mechanisms of Synergistic Antileukemic Interactions between Valproic Acid and Cytarabine in Pediatric Acute Myeloid Leukemia
- (2010) C. Xie et al. CLINICAL CANCER RESEARCH
- Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia
- (2010) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
- (2010) Peter Paschka et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Clinical Study of Tosedostat, an Inhibitor of Aminopeptidases, in Patients With Acute Myeloid Leukemia and Myelodysplasia
- (2010) Bob Löwenberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial
- (2010) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- The Feasibility of Plerixafor as a Second-line Stem Cell Mobilizing Agent in Children
- (2010) Kanakkande Aabideen et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
- (2010) Jeffrey E Rubnitz et al. LANCET ONCOLOGY
- TET2 mutations in childhood leukemia
- (2010) S M C Langemeijer et al. LEUKEMIA
- Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias
- (2010) A S Moore et al. LEUKEMIA
- Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study
- (2010) P A Ho et al. LEUKEMIA
- FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657
- (2010) Bianca F. Goemans et al. LEUKEMIA RESEARCH
- Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemia
- (2010) Christopher Jenkins et al. LEUKEMIA RESEARCH
- The FLT3 Internal Tandem Duplication Mutation Is a Secondary Target of the Aurora B Kinase Inhibitor AZD1152-HQPA in Acute Myelogenous Leukemia Cells
- (2010) M. Grundy et al. MOLECULAR CANCER THERAPEUTICS
- DNMT3AMutations in Acute Myeloid Leukemia
- (2010) Timothy J. Ley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study
- (2010) Matthew F. Gorman et al. PEDIATRIC BLOOD & CANCER
- Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing program
- (2010) Stephen T. Keir et al. PEDIATRIC BLOOD & CANCER
- Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium
- (2010) Yoav Messinger et al. PEDIATRIC BLOOD & CANCER
- FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML
- (2009) K. W. Pratz et al. BLOOD
- Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study
- (2009) Christian M. Zwaan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Structural and Functional Alterations of FLT3 in Acute Myeloid Leukemia
- (2009) S. Meshinchi et al. CLINICAL CANCER RESEARCH
- A phase 2 study of vorinostat in acute myeloid leukemia
- (2009) E. W. Schaefer et al. HAEMATOLOGICA
- Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia
- (2009) Sima Jeha et al. JOURNAL OF CLINICAL ONCOLOGY
- Second Neoplasms in Survivors of Childhood Cancer: Findings From the Childhood Cancer Survivor Study Cohort
- (2009) Anna T. Meadows et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
- (2009) John F. DiPersio et al. JOURNAL OF CLINICAL ONCOLOGY
- A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
- (2009) N Hijiya et al. LEUKEMIA
- Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial
- (2009) J E Rubnitz et al. LEUKEMIA
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response
- (2008) K. W. Pratz et al. BLOOD
- CHR-2797: An Antiproliferative Aminopeptidase Inhibitor that Leads to Amino Acid Deprivation in Human Leukemic Cells
- (2008) D. Krige et al. CANCER RESEARCH
- Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia
- (2008) E. C. Attar et al. CLINICAL CANCER RESEARCH
- Safety and Efficacy of Gemtuzumab Ozogamicin in Combination With Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report From The Children's Oncology Group
- (2008) Richard Aplenc et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia
- (2008) Weiguo Zhang et al. JNCI-Journal of the National Cancer Institute
- Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemia
- (2008) S. Hu et al. MOLECULAR CANCER THERAPEUTICS
- Evolving Strategies for the Management of Hand-Foot Skin Reaction Associated with the Multitargeted Kinase Inhibitors Sorafenib and Sunitinib
- (2008) M. E. Lacouture et al. ONCOLOGIST
- Acute Myeloid Leukemia
- (2008) Jeffrey E. Rubnitz et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Initial testing of dasatinib by the pediatric preclinical testing program
- (2007) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Fatal skin and liver toxicity in a patient treated with clofarabine
- (2007) Donna L. Johnston et al. PEDIATRIC BLOOD & CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started